Relay Therapeutics, Inc. (RLAY)
USD 4.2
(-6.67%)
USD 4.2
(-6.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 25.54 Million | 1.38 Million | 3.02 Million | 82.65 Million | - | - |
| Cost of Revenue | 326.38 Million | 4.13 Million | 3.92 Million | 3.54 Million | 2.84 Million | 2.15 Million |
| Gross Profit | -300.84 Million | -2.74 Million | -896 Thousand | 79.1 Million | -2.84 Million | -2.15 Million |
| Operating Expenses | 72.15 Million | 312.33 Million | 230.03 Million | 138.45 Million | 84.04 Million | 49.88 Million |
| Selling, General and Administrative Expenses | 74.95 Million | 65.97 Million | 57.38 Million | 38.58 Million | 13.74 Million | 8.85 Million |
| Research and Development Expenses | 330.01 Million | 246.35 Million | 172.65 Million | 99.86 Million | 70.3 Million | 41.03 Million |
| Other Expenses | - | -20 Thousand | -4000.00 | -16 Thousand | -58 Thousand | -9000.00 |
| Cost and Expenses | 398.54 Million | 312.33 Million | 230.03 Million | 138.45 Million | 84.04 Million | 49.88 Million |
| Operating Income | -373 Million | -299.27 Million | -364.69 Million | -55.79 Million | -84.04 Million | -49.88 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -36.25 Million | 132.93 Million | -3.4 Million | -8.8 Million | 1.1 Million |
| Earnings before Tax | -341.97 Million | -290.5 Million | -363.87 Million | -52.41 Million | -75.3 Million | -48.78 Million |
| Net Income | -341.97 Million | -254.25 Million | -496.8 Million | -49.01 Million | -66.5 Million | -48.78 Million |
| Earnings Per Share Basic | -2.79 | -2.27 | -5.22 | -1.15 | -15.53 | -19.63 |
| Earnings Per Share Diluted | -2.79 | -2.27 | -5.22 | -1.15 | -15.53 | -19.63 |
| Weighted Average Shares Outstanding | 122.57 Million | 112.23 Million | 95.13 Million | 42.61 Million | 4.28 Million | 2.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 122.57 Million | 112.23 Million | 95.13 Million | 42.61 Million | 4.28 Million | 2.48 Million |
| Gross Margin | -11.78 | -1.99 | -0.30 | 0.96 | - | - |
| EBIT Margin | -14.65 | -233.62 | -29.49 | -0.63 | - | - |
| Profit Margin | -13.39 | -184.11 | -164.02 | -0.59 | - | - |
| EBITDA | -374.15 Million | -306.82 Million | -222.18 Million | -52.24 Million | -81.2 Million | -47.73 Million |
| Earnings Before Tax Margin | -14.60 | -216.71 | -120.40 | -0.68 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 10 Million | 25.54 Million | -1000.00 | 25.2 Million | 119 Thousand |
| Cost of Revenue | 1.36 Million | 1.39 Million | 5.26 Million | 1.37 Million | 1.36 Million | 1.33 Million |
| Gross Profit | -1.36 Million | 8.61 Million | 20.27 Million | -1.37 Million | 23.83 Million | -1.21 Million |
| Operating Expenses | 110.76 Million | 100.8 Million | 404.96 Million | 94.26 Million | 99.97 Million | 108.32 Million |
| Selling, General and Administrative Expenses | 18.77 Million | 18.4 Million | - | 16.76 Million | 18.48 Million | 20.12 Million |
| Research and Development Expenses | 91.99 Million | 82.4 Million | - | 77.49 Million | 81.49 Million | 88.2 Million |
| Other Expenses | -2000.00 | 25 Thousand | -18 Thousand | 1000.00 | -2000.00 | -14 Thousand |
| Cost and Expenses | 112.13 Million | 102.2 Million | 404.96 Million | 94.26 Million | 99.97 Million | 108.32 Million |
| Operating Income | -112.13 Million | -92.19 Million | -373 Million | -92.19 Million | -73.57 Million | -106.05 Million |
| Interest Expense | - | - | - | 6.93 Million | - | - |
| Income Tax Expense | - | 1.35 Million | -37.46 Million | 18.01 Million | -1.36 Million | -9.71 Million |
| Earnings before Tax | -92.21 Million | -81.38 Million | -341.97 Million | -83.49 Million | -65.73 Million | -98.5 Million |
| Net Income | -92.21 Million | -81.38 Million | -341.97 Million | -83.49 Million | -65.73 Million | -98.5 Million |
| Earnings Per Share Basic | -0.69 | -0.62 | - | -0.68 | -0.54 | -0.81 |
| Earnings Per Share Diluted | -0.69 | -0.62 | - | -0.68 | -0.54 | -0.81 |
| Weighted Average Shares Outstanding | 132.82 Million | 130.84 Million | 122.57 Million | 122.57 Million | 122.23 Million | 121.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 132.82 Million | 130.84 Million | 122.57 Million | 122.57 Million | 122.23 Million | 121.68 Million |
| Gross Margin | - | 0.86 | 0.79 | 1376.00 | 0.95 | -10.21 |
| EBIT Margin | - | -9.07 | - | 94.95 Thousand | -2.92 | -916.13 |
| Profit Margin | - | -8.13 | -13.39 | 83.49 Thousand | -2.61 | -827.77 |
| EBITDA | -110.76 Million | -90.8 Million | - | -94.95 Million | -73.57 Million | -109.02 Million |
| Earnings Before Tax Margin | - | -9.21 | -14.60 | 92.19 Thousand | -2.92 | -891.18 |
BFISH
AUTME
POR
STRR
393890
AFH